Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,910 | -13,499 | -8,161 | -5,433 | -1,903 |
| Depreciation Amortization | 1,918 | 2,467 | 1,870 | 1,256 | 636 |
| Accounts receivable | 155 | 1,712 | 1,627 | 1,306 | -128 |
| Accounts payable and accrued liabilities | -185 | -1,190 | -1,319 | -1,178 | -781 |
| Other Working Capital | 66 | -1,253 | -996 | -597 | -1,583 |
| Other Operating Activity | 1,002 | -1,739 | -3,837 | -2,837 | -1,423 |
| Operating Cash Flow | $-2,954 | $-13,502 | $-10,816 | $-7,483 | $-5,182 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,528 | -1 | -7,400 | -3,328 | -2,327 |
| PPE Investments | 21 | -57 | -98 | -123 | -121 |
| Other Investing Activity | 21 | 17,796 | 14,973 | 17 | 3 |
| Investing Cash Flow | $-4,486 | $17,738 | $7,475 | $-3,434 | $-2,445 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -10,000 | N/A | N/A |
| Common Stock Issued | 3,206 | 4,283 | 4,283 | 4,283 | N/A |
| Other Financing Activity | -213 | -10,885 | -629 | -293 | -159 |
| Financing Cash Flow | $2,993 | $-6,602 | $-6,346 | $3,990 | $-159 |
| Exchange Rate Effect | 2 | 21 | 12 | 25 | -20 |
| Beginning Cash Position | 12,956 | 15,301 | 15,301 | 15,301 | 15,301 |
| End Cash Position | 8,511 | 12,956 | 5,626 | 8,329 | 7,495 |
| Net Cash Flow | $-4,445 | $-2,345 | $-9,675 | $-6,972 | $-7,806 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,954 | -13,502 | -10,816 | -7,483 | -5,182 |
| Capital Expenditure | -2 | -135 | -129 | -123 | -121 |
| Free Cash Flow | -2,956 | -13,637 | -10,945 | -7,606 | -5,303 |